NERV 8-K: SEC filing

Filed with the SEC on · accession 0001193125-26-462005

NERV filed a 8-K (current report) with the SEC on Nov 16, 2026. Minerva Neurosciences furnished a revised transcript of a key opinion leader event regarding its roluperidone product candidate, removing a Q&A session that contained statements about potential FDA approval and safety.

Summary of the filing

Minerva Neurosciences furnished a revised transcript of a key opinion leader event regarding its roluperidone product candidate, removing a Q&A session that contained statements about potential FDA approval and safety. The company clarified that these statements were personal opinions and not assurances of FDA approval, and that any NDA resubmission depends on C19 trial results.

Key details

RegistrantMinerva Neurosciences, Inc.
Regulatory agencyU.S. Food and Drug Administration (FDA)
Regulatory counselFrank Sasinowski
Chief financial officerFred Ahlholm

✦ Ask GOAX AI about this filing — what it means for NERV, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for NERV?

Click here

Frequently asked questions

What did NERV file with the SEC on Nov 16, 2026?

NERV filed a 8-K (SEC filing). Minerva Neurosciences furnished a revised transcript of a key opinion leader event regarding its roluperidone product candidate, removing a Q&A session that contained statements about potential FDA approval and safety. The company clarified that these statements were personal opinions and not assurances of FDA approval, and that any NDA resubmission depends on C19 trial results.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other NERV SEC filings

Get alerts when NERV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days